Upgrade for Complete Access See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Harvard Business School
AstraZeneca
Johnson and Johnson
Express Scripts
Dow

Last Updated: June 27, 2022

Drug Price Trends for CAPSAICIN


✉ Email this page to a colleague

« Back to Dashboard

Drug Price Trends for CAPSAICIN

Average Pharmacy Cost for CAPSAICIN

These are average pharmacy acquisition costs (net of discounts) from a US national survey
Drug Name NDC Price/Unit ($) Unit Date
CAPSAICIN 0.025% CREAM 00536-2525-25 0.07808 GM 2021-06-23
CAPSAICIN 0.025% CREAM 00536-2525-25 0.09588 GM 2021-05-19
CAPSAICIN 0.025% CREAM 00536-2525-25 0.08421 GM 2021-04-21
CAPSAICIN 0.025% CREAM 00536-2525-25 0.09370 GM 2021-03-17
>Drug Name >NDC >Price/Unit ($) >Unit >Date

Best Wholesale Price for CAPSAICIN

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available to any customer under comparable terms and conditions
Drug Name Vendor NDC Count Price ($) Price/Unit ($) Unit Dates Price Type
A2A ARTHRITIS 0.1% CREAM,TOP A2A Alliance Pharmaceuticals, LLC 73141-0559-02 68GM 10.65 0.15662 GM 2022-03-15 - 2027-03-14 FSS
CAPSAICIN 0.075% CREAM,TOP Sheffield Pharmaceuticals LLC, DBA Sheffield Pharmaceuticals 11527-0080-60 60GM 3.25 0.05417 GM 2021-10-01 - 2026-09-30 FSS
CAPSAICIN 0.025% CREAM,TOP Sheffield Pharmaceuticals LLC, DBA Sheffield Pharmaceuticals 11527-0089-60 60GM 2.14 0.03567 GM 2021-10-01 - 2026-09-30 FSS
QUTENZA 8% Averitas Pharma Inc. 72512-0928-01 1 655.70 655.70000 EACH 2021-01-01 - 2024-04-30 Big4
>Drug Name >Vendor >NDC >Count >Price ($) >Price/Unit ($) >Unit >Dates >Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Medtronic
Boehringer Ingelheim
Colorcon
Harvard Business School
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.